-
公开(公告)号:EP3615080A1
公开(公告)日:2020-03-04
申请号:EP18724677.2
申请日:2018-04-26
发明人: DUBENSKY, Thomas W. Jr. , BRUML, Jacob, Robert , CANHAM, Stephen , CHO, Charles, Y. , GAUTHIER, Kelsey , GLICKMAN, Laura, Hix , HAO, Xueshi , KANNE, David , KASIBHATLA, Shailaja , KATIBAH, George, Edwin , LE, Thanh Ngoc, Lan , LEONG, Justin , MCKENNA, Jeffrey , MCWHIRTER, Sarah , NDUBAKU, Chudi Obioma , OU, Weijia , SUNG, Leonard , TRIA, George, Scott , UNO, Tetsuo , WU, Tom, Yao-hsiang , WAN, Yongqin , DUBENSKY, Thomas W. Jr.
-
公开(公告)号:EP3615548A1
公开(公告)日:2020-03-04
申请号:EP18725304.2
申请日:2018-04-26
申请人: Aduro Biotech, Inc. , Novartis AG
IPC分类号: C07H21/02 , A61K31/7084 , A61K47/26 , A61P35/00
-
公开(公告)号:EP3507367A1
公开(公告)日:2019-07-10
申请号:EP17824754.0
申请日:2017-07-01
申请人: Aduro BioTech, Inc. , Novartis AG
发明人: KANNE, David, Braun , NDUBAKU, Chudi, Obioma , BRUML, Jacob, Robert , LE, Thanh Ngoc Lan , MCKENNA, Jeffrey , TRIA, George, Scott , CANHAM, Stephen
IPC分类号: C12N15/113
-
公开(公告)号:EP3022201A1
公开(公告)日:2016-05-25
申请号:EP14766209.2
申请日:2014-07-16
申请人: Novartis AG
发明人: BAETTIG, Urs , BEATTIE, David , LEGRAND, Darren Mark , LISTER, Andrew Stuart , MCKENNA, Jeffrey , PEARCE, David William , SANDHAM, David Andrew , STANLEY, Emily , STEWARD, Oliver Ross , THOMSON, Christopher
IPC分类号: C07D403/12 , C07D401/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07D257/04 , A61K31/41 , A61P35/00
CPC分类号: C07D401/12 , A61K45/06 , C07D257/04 , C07D403/12 , C07D405/12 , C07D407/12 , C07D413/12 , C07D417/12
摘要: The present invention relates to novel compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in diseases and disorders mediated by autotaxin.
摘要翻译: 本发明涉及自体贴剂抑制剂的新型化合物,其制备方法,药物组合物和含有它们的药物及其在自体吸收素介导的疾病和病症中的用途。
-
公开(公告)号:EP2935278B1
公开(公告)日:2017-03-15
申请号:EP13826625.9
申请日:2013-12-17
申请人: Novartis AG
发明人: AHMED, Mahbub , ASHALL-KELLY, Alexander , GUERITZ, Louisa , MCKENNA, Jeffrey , MCKENNA, Joseph , MUTTON, Simon , PARMAR, Rakesh , SHEPHERD, Jon , WRIGHT, Paul
IPC分类号: C07D487/14 , C07D487/04 , C07D495/14 , A61K31/519 , A61P13/12 , A61P1/12
CPC分类号: C07D513/14 , A61K31/519 , A61K31/542 , A61K31/55 , A61K45/06 , C07D471/14 , C07D487/04 , C07D487/14 , C07D487/22 , C07D495/14 , C07D513/00
-
6.
公开(公告)号:EP2935277A1
公开(公告)日:2015-10-28
申请号:EP13826624.2
申请日:2013-12-17
申请人: Novartis AG
发明人: AHMED, Mahbub , ASHALL-KELLY, Alexander , BLOOMFIELD, Graham Charles , GUERITZ, Louisa , MCKENNA, Jeffrey , MCKENNA, Joseph , MUTTON, Simon , PARMAR, Rakesh , SHEPHERD, Jon , WRIGHT, Paul
IPC分类号: C07D487/14 , C07D498/14 , A61K31/519 , A61K31/5383 , A61P1/12
CPC分类号: C07D487/14 , A61K31/519 , A61K31/5383 , A61K31/553 , A61K45/06 , C07D498/14
摘要: The present invention provides a CFTR inhibitor of formula (I) or a pharmaceutically acceptable salt thereof; and its therapeutic uses, e.g. in the treatment of diarrhea. The present invention further provides a combination of pharmacological active agents and a pharmaceutical composition.
摘要翻译: 本发明提供式I化合物或其药学上可接受的盐; 及其治疗用途。 本发明还提供药理活性剂和药物组合物的组合。
-
7.PYRAZOLO[5,1B]OXAZOLE DERIVATIVES AS CRF-1 RECEPTOR ANTAGONISTS 有权
标题翻译: 吡唑并[5,1B-]恶唑衍生物作为CRF-1受体拮抗剂公开(公告)号:EP2531510B1
公开(公告)日:2014-07-23
申请号:EP11701662.6
申请日:2011-01-28
申请人: Novartis AG
IPC分类号: C07D491/048 , A61K31/4162 , A61P1/00 , A61P25/00 , A61P39/00
CPC分类号: C07D491/048
-
8.
公开(公告)号:EP2714690A1
公开(公告)日:2014-04-09
申请号:EP12727947.9
申请日:2012-05-25
申请人: Novartis AG
发明人: AMBARKHANE, Ameet Vijay , BHALAY, Gurdip , BECKETT, Martin , DALE, James , HAMADI, Ahmed , MAZZACANI, Alessandro , MCKENNA, Jeffrey , THOMSON, Christopher
IPC分类号: C07D471/10 , C07D487/10 , A61K31/438 , A61P1/00
CPC分类号: C07D471/10 , A61K31/407 , A61K31/435 , A61K31/55 , A61K45/06 , C07D487/10
摘要: The invention relates to derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of a disorder or a disease mediated by the ghrelin receptor.
-
公开(公告)号:EP2328902A1
公开(公告)日:2011-06-08
申请号:EP09804561.0
申请日:2009-08-04
申请人: Novartis AG
发明人: BRUCE, Ian , CULSHAW, Andrew James , DEVEREUX, Nicholas James , GESSIER, François , MCKENNA, Jeffrey , NEEF, James , OAKMAN, Helen Elizabeth
IPC分类号: C07D498/04 , A61K31/424 , A61P43/00
CPC分类号: C07D498/04
摘要: There are described pyrazolo [5.1 -b] oxazole derivatives of structure I useful as corticotropin releasing factor (CRF
1 ) receptor antagonists.-
公开(公告)号:EP3863642A1
公开(公告)日:2021-08-18
申请号:EP19872219.1
申请日:2019-10-09
发明人: SPRADLIN, Jessica , WARD, Carl, C. , NOMURA, Daniel, K. , SCHIRLE, Markus , TALLARICO, John, A. , MCKENNA, Jeffrey , MAIMONE, Thomas, John , HU, Xirui
IPC分类号: A61K31/5517 , A61K31/551 , C07D487/04 , C07D495/14
-
-
-
-
-
-
-
-
-